Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Home
Zydus Lifesciences Limited
Press Release Feb 27 2026
Business
Feb 27 2026
3 min read

Press Release Feb 27 2026

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Zydus Lifesciences announces successful clinical development of Pembrolizumab biosimilar FYB206, marking a milestone toward USFDA filing".

View Attachment